References
- W A. The surgical therapy of hyperinsulinsm. J Int de Chir. 1938;3:337–376.
- Carpentier M, L B. Benadering van een patiënt met spontane hypoglycemie. Tijdschr Geneeskd. 2017;73:212–219.
- Iglesias P, Díez JJ. Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur J Endocrinol. 2014;170(4):R147–57.
- Fort-Culillas R, Barahona San Millán R, Garcia-Fructuoso I, et al. Doege-Potter syndrome in a facial solitary fibrous tumor: diagnose and clinical management discussion. Clin Case Rep. 2021;9(6):e04291. DOI:10.1002/ccr3.4291
- de Pinieux G, Karanian M, Le Loarer F, et al. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS ONE. 2021;16(2):e0246958. DOI:10.1371/journal.pone.0246958
- Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab. 2014;99(3):713–722.
- Van Doorn CMH J, Jansen M, van Buul-Offers SC. Insuline-achtige groeifactor (IGF)-II: biologische eigenschappen en de klinische relevantie. Ned Tijdschr Klin Chem. 2002;27:163–169.
- van Doorn J. Insulin-like growth factor-II and bioactive proteins containing a part of the E-domain of pro-insulin-like growth factor-II. BioFactors. 2020;46(4):563–578.
- Mohammed T, Ozcan G, Siddique AS, et al. Doege-Potter syndrome with a benign solitary fibrous tumor: a case report and literature review. Case Rep Oncol. 2021;14(1):470–476.
- Dynkevich Y, Rother KI, Whitford I, et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev. 2013;34(6):798–826. DOI:10.1210/er.2012-1033
- Fung EC, Crook MA. Doege-Potter syndrome and ‘big-IGF2’: a rare cause of hypoglycaemia. Ann Clin Biochem. 2011;48(Pt 2):95–96.
- Solsi A, Pho K, Shojaie S, et al. Doege-Potter syndrome and Pierre-Marie-Bamberger syndrome in a patient with pleural solitary fibrous tumor: a rare case with literature review. Cureus. 2020;12(5):e7919.
- Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–728. DOI:10.1210/jc.2008-1410
- Kittah NE, Vella A. Management of endocrine disease: pathogenesis and management of hypoglycemia. Eur J Endocrinol. 2017;177(1):R37–r47.
- Schutt RC, Gordon TA, Bhabhra R, et al. Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report. J Med Case Rep. 2013;7:11.
- Foreman RE, Meek CL, Roberts GP, et al. LC-MS/MS based detection of circulating proinsulin derived peptides in patients with altered pancreatic beta cell function. J Chromatogr B. 2022;1211:123482.
- Tsuro K, Kojima H, Okamoto S, et al. Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-II-producing solitary fibrous tumor. Intern Med. 2006;45(8):525–529. DOI:10.2169/internalmedicine.45.1611
- van Houdt WJ, Westerveld CM, Vrijenhoek JE, et al. Prognosis of solitary fibrous tumors: a multicenter study. Ann Surg Oncol. 2013;20(13):4090–4095. DOI:10.1245/s10434-013-3242-9
- Davanzo B, Emerson RE, Lisy M, et al. Solitary fibrous tumor Transl Gastroenterol Hepatol 2018 Nov: 21:3:94
- Kallen ME, Hornick JL The 2020 WHO classification: what’s new in soft tissue tumor pathology? Am J Surg Pathol 2021 Jan;45(1):e1–23